Owner Elan Pharma International Limited

Inventors Fanning, Niall M M.; Devane, John G.; Stark, Paul

Agent FB Rice

Pub. Number AU-B-2009201786

Parent 2007203497

Filing date 5 May 2009

Wipo publication date 28 May 2009

Acceptance publication date 23 February 2012

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 9/24 (2006.01) Medicinal preparations characterised by special physical form - Layered or laminated unitary dosage forms

A61K 9/26 (2006.01) Medicinal preparations characterised by special physical form - Discrete particles in supporting matrix

A61K 9/40 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 9/50 (2006.01) Medicinal preparations characterised by special physical form - Microcapsules

A61K 9/54 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/56 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/58 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/62 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/4458 (2006.01) - only substituted in position 2, e.g. methylphenidate

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups